FinscoFinsco

IDEXX Laboratories Inc (US.IDXX)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.IDXX · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion87.3%→
ROE17.9%↑
Cash Conversion95.6%→
D/E Ratio0.71→
Gross Margin63.4%→
US.IDXX (IDEXX Laboratories Inc) | YoY: 2026 Q1 vs 2025 Q1


Metric           Value  YoY
---------------------------
FCF Conversion   87.3%    →
ROE              17.9%    ↑
Cash Conversion  95.6%    →
D/E Ratio         0.71    →
Gross Margin     63.4%    →
Key Metrics
US.IDXX (IDEXX Laboratories Inc) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
---------------------------
FCF Conversion 87.3% →
ROE 17.9% ↑
Cash Conversion 95.6% →
D/E Ratio 0.71 →
Gross Margin 63.4% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies